Dasiglucagon demonstrates reduced costs in the treatment of severe hypoglycemia in a budget impact model von Hinahara, Jordan, Weinzimer, Stuart A, Bromley, Emilie R, Goss, Thomas F, Kendall, David M, Hammer, Mette

Volltext